
ARTICLES ON VALVULOPATHIES
Results of the COAPT Study at 5 Years: Sustained Benefit of the MitraClip When Surgery Is Not Feasible?
The COAPT study’s 5-year outcomes assess clinical parameters and mortality in patients with severe secondary mitral regurgitation (MR) after MitraClip implantation.
On-X mitral: Is Reduced Oral Anticoagulation Feasible?
This study is a randomized, multicenter, prospective, open clinical trial comparing clinical outcomes 3 months after implanting an On-X mechanical mitral prosthesis in patients with standard anticoagulation ranges versus a lower target.
Percutaneous Tricuspid Repair: The Definitive Treatment for Moderate- or High-Risk Surgical Patients?
This is a multicenter, randomized clinical trial evaluating outcomes of transcatheter edge-to-edge tricuspid valve repair compared to optimized medical management in 350 patients with severe tricuspid regurgitation.
Transcatheter aortic valve implantation versus surgical aortic valve replacement in aortic insufficiency: is it justified?
Analysis of post-procedure outcomes and mid-term follow-up of TAVI vs. SVA in a U.S. healthcare insurance database for patients with pure aortic insufficiency.
Conventional aortic valve replacement versus transcatheter implantation in patients with bicuspid valve: is it a good idea?
This retrospective American study evaluates short- and mid-term outcomes in a cohort of 56,331 patients with severe aortic stenosis and bicuspid aortic valve (BAV) undergoing conventional aortic valve replacement (AVR) or transcatheter implantation (TAVI).
Current state of aortic valve replacement surgery in 2023
Review article examining the boundaries of TAVI indication in favor of aortic valve replacement based on currently available evidence.
Update on alternative access for transcatheter aortic valve implantation (TAVI)
A comparative review of different non-transfemoral alternative access options for TAVI, with the objective of providing updated information on the latest techniques, outcomes, and advances in the field.
What is the Prosthetic of Choice in Rheumatic Mitral Valve Disease?
This nationwide retrospective study from Taiwan evaluates outcomes of biological versus mechanical mitral valve replacement in 1,576 patients.
The diverse facets of primary mitral regurgitation
This retrospective, multicenter study utilizes latent class analysis on 2321 patients undergoing surgery for primary mitral valve disease, aiming to identify phenotypes with distinct long-term prognoses.
Transapical neochord implantation: a promising future
This study evaluates the five-year clinical and echocardiographic outcomes of patients with severe degenerative mitral regurgitation (MR) treated with transapical neochord implantation using the NeoChord DS 1000® device.